Search for: "Watson Pharmaceuticals Inc"
Results 161 - 180
of 224
Sort by Relevance
|
Sort by Date
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
23 Nov 2010, 2:19 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
14 Nov 2010, 8:48 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-01969; filed November 11, 2010 in the District Court of Nevada • Plaintiffs: Astrazeneca UK Ltd.; IPR Pharmaceuticals, Inc.; Shionogi Seiyaku Kabushiki Kaisha • Defendants: Watson Pharmaceuticals, Inc.; Watson Pharma, Inc.; Watson Laboratories, Inc. [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
6 Oct 2010, 4:22 am
Sandoz, Inc. et al (Docket Report) [read post]
27 Sep 2010, 12:59 am
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
23 Sep 2010, 12:39 pm
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
15 Sep 2010, 2:15 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
5 Aug 2010, 2:08 pm
Wyeth Laboratories, Inc., 533 N.E.2d 748 (Ohio 1988) (the Ohio Supreme Court rejecting the theory). [read post]
28 Jul 2010, 12:06 am
Watson Laboratories, Inc. [read post]
14 Jul 2010, 7:53 am
Watson Pharmaceuticals, Inc., 211 F.3d 21 (2d Cir. 2000). [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
24 May 2010, 7:46 am
Mazda Motor of America, Inc. [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
13 May 2010, 4:58 pm
Watson Pharmaceuticals Inc. et al. [read post]
9 May 2010, 9:58 pm
Watson Pharmaceuticals, Inc. et al. 2:10-cv-00647; filed May 5, 2010 in the District Court of Nevada • Plaintiff: Eli Lilly & Company • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
5 May 2010, 4:46 am
Watson Pharmaceuticals, Inc. et al. [read post]
